肾移植受者的心血管疾病：全面排查，不留死角。 - Suppr

Suppr

超能文献

Cardiovascular disease in kidney transplant recipients: leave no stone unturned.

作者信息

Van Laecke Steven, Abramowicz Daniel

机构信息

Department of Internal Medicine, Renal Division, University Hospital Ghent, Ghent, Belgium.

Department of Nephrology and Hypertension, University Hospital Antwerp, Edegem, Belgium.

出版信息

Nephrol Dial Transplant. 2019 May 1;34(5):727-730. doi: 10.1093/ndt/gfz084.

DOI:10.1093/ndt/gfz084

PMID:31062030

Abstract

摘要

相似文献

Cardiovascular disease in kidney transplant recipients: leave no stone unturned.

Nephrol Dial Transplant. 2019 May 1;34(5):727-730. doi: 10.1093/ndt/gfz084.

Cardiovascular diseases in kidney transplant recipients: the role of anemia.

Adv Chronic Kidney Dis. 2004 Jul;11(3):328-33. doi: 10.1053/j.arrt.2004.04.003.

Subclinical cardiovascular changes in pediatric solid organ transplant recipients: A systematic review and meta-analysis.

Pediatr Transplant. 2016 Jun;20(4):530-9. doi: 10.1111/petr.12689. Epub 2016 Feb 18.

The Risk of Cardiovascular Disease Is Not Increasing Over Time Despite Aging and Higher Comorbidity Burden of Kidney Transplant Recipients.

Transplantation. 2017 Mar;101(3):588-596. doi: 10.1097/TP.0000000000001155.

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney Transplantation: A Population Cohort Study.

Am J Kidney Dis. 2018 Jan;71(1):102-111. doi: 10.1053/j.ajkd.2017.08.018. Epub 2017 Nov 28.

Haptoglobin 2-2 Genotype, Patient, and Graft Survival in Renal Transplant Recipients.

Prog Transplant. 2017 Dec;27(4):386-391. doi: 10.1177/1526924817732020. Epub 2017 Sep 22.

Cardiovascular disease burden and risk factors before and after kidney transplant.

Cardiovasc Hematol Disord Drug Targets. 2014;14(3):185-94. doi: 10.2174/1871529x14666140401112654.

Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.

Am J Kidney Dis. 2016 Aug;68(2):277-286. doi: 10.1053/j.ajkd.2016.01.019. Epub 2016 Mar 2.

Risk factors profile and cardiovascular events in solid organ transplant recipients.

Iran J Kidney Dis. 2012 Jan;6(1):9-13.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Cochrane Database Syst Rev. 2009 Apr 15(2):CD005019. doi: 10.1002/14651858.CD005019.pub3.

引用本文的文献

Changes in Cardiac Structure and Function of Recipients after Kidney Transplantation.

J Clin Med. 2024 Jun 20;13(12):3629. doi: 10.3390/jcm13123629.

Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study.

Nephrol Dial Transplant. 2020 Mar 1;35(3):512-519. doi: 10.1093/ndt/gfz288.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cardiovascular disease in kidney transplant recipients: leave no stone unturned.

作者信息

Van Laecke Steven, Abramowicz Daniel

机构信息

Department of Internal Medicine, Renal Division, University Hospital Ghent, Ghent, Belgium.

Department of Nephrology and Hypertension, University Hospital Antwerp, Edegem, Belgium.

出版信息

Nephrol Dial Transplant. 2019 May 1;34(5):727-730. doi: 10.1093/ndt/gfz084.

DOI:10.1093/ndt/gfz084

PMID:31062030

Abstract

摘要

相似文献

Cardiovascular disease in kidney transplant recipients: leave no stone unturned.

Nephrol Dial Transplant. 2019 May 1;34(5):727-730. doi: 10.1093/ndt/gfz084.

Cardiovascular diseases in kidney transplant recipients: the role of anemia.

Adv Chronic Kidney Dis. 2004 Jul;11(3):328-33. doi: 10.1053/j.arrt.2004.04.003.

Subclinical cardiovascular changes in pediatric solid organ transplant recipients: A systematic review and meta-analysis.

Pediatr Transplant. 2016 Jun;20(4):530-9. doi: 10.1111/petr.12689. Epub 2016 Feb 18.

The Risk of Cardiovascular Disease Is Not Increasing Over Time Despite Aging and Higher Comorbidity Burden of Kidney Transplant Recipients.

Transplantation. 2017 Mar;101(3):588-596. doi: 10.1097/TP.0000000000001155.

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney Transplantation: A Population Cohort Study.

Am J Kidney Dis. 2018 Jan;71(1):102-111. doi: 10.1053/j.ajkd.2017.08.018. Epub 2017 Nov 28.

Haptoglobin 2-2 Genotype, Patient, and Graft Survival in Renal Transplant Recipients.

Prog Transplant. 2017 Dec;27(4):386-391. doi: 10.1177/1526924817732020. Epub 2017 Sep 22.

Cardiovascular disease burden and risk factors before and after kidney transplant.

Cardiovasc Hematol Disord Drug Targets. 2014;14(3):185-94. doi: 10.2174/1871529x14666140401112654.

Am J Kidney Dis. 2016 Aug;68(2):277-286. doi: 10.1053/j.ajkd.2016.01.019. Epub 2016 Mar 2.

Risk factors profile and cardiovascular events in solid organ transplant recipients.

Iran J Kidney Dis. 2012 Jan;6(1):9-13.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Cochrane Database Syst Rev. 2009 Apr 15(2):CD005019. doi: 10.1002/14651858.CD005019.pub3.

引用本文的文献

Changes in Cardiac Structure and Function of Recipients after Kidney Transplantation.

J Clin Med. 2024 Jun 20;13(12):3629. doi: 10.3390/jcm13123629.

Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study.

Nephrol Dial Transplant. 2020 Mar 1;35(3):512-519. doi: 10.1093/ndt/gfz288.